РинФаст - analogs
Components: Insulin aspart |
|||||||||
Pharmgroups: Insulins || Short-acting insulins |
|||||||||
| Prices in pharmacies: — Instructions РинФаст | |||||||||
|
ⓘ✘Enter drugs for checking interactions through a quick button search . |
|
ⓘ✘ diseases to evaluate contraindications and side effects through a quick search. | ||||||
Начиная работу с сервисом, вы принимаете соглашение пользователя. Kiberis do not replace the doctor!
| Similar | Complete analog ⓘ✘Analogues of the drug with completely identical active ingredients |
Prices in pharmacies |
| ≈100% | NovoRapid Penfill | 15.5-18.3€ |
| ≈100% | NovoRapid FlexPen | 17.2-18.8€ |
| ≈100% | Fiasp | 19.2€ |
| ≈100% | Insulin aspart | — |
-
Similar
Prices in
pharmaciesAnalogs by action ⓘ✘Analogues of the drug according to its degree of similarity with other drugs that are not direct analogues
- 80% 29.4-30.3€ Rayzodeg [Insulin degludec+Insulin aspart and more 2Insulin degludec, Insulin aspart]
- 73% 13.2-13.9€ NovoMix 30 FlexPen [Insulin aspart biphasic and more 1Insulin aspart]
- 71% — Росинсулин аспарт [Insulin aspart and more 1Aspartame]
- 70% 27.4-47.9€ Toujeo Solostar [Insulin glargine]
- 70% 15.9-17.2€ Humalog [Insulin lispro]
- 70% 17.4€ РинЛиз [Insulin lispro]
- 70% 4.2-5.9€ Glucobay [Acarbose]
- 68% — RYZODEG [Insulin degludec+Insulin aspart and more 2Insulin degludec, Insulin aspart]
- 66% — Росинсулин аспарт р [Insulin aspart and more 1Aspartame]
- 65% 4.9-6.6€ Actrapid HM Penfill [Insulin soluble [human biosynthetic] and more 1Insulin human]
- 64% 31.7€ РинГлар [Insulin glargine]
- 63% — РОСИНСУЛИН ГЛАРГИН 300 [Insulin glargine]
- 63% — Базаглар [Insulin glargine]
- 62% 5.2-12.6€ Biosulin R [Insulin soluble [human biosynthetic]]
- 62% 4.7-16.6€ Rinsulin R [Insulin soluble [human biosynthetic] and more 1Insulin human]
- 62% 8-10.2€ Humulin M3 [Insulin biphasic [human biosynthetic] and more 1Insulin human]
- 62% — B-Insulin S.C. Berlin-Chemie [Insulin-aminoquinuride [pork monocomponent]]
- 61% — Humulin M2 20/80 [Insulin biphasic [human biosynthetic]]
- 61% — Rinsulin Mix 30/70 [Insulin biphasic [human biosynthetic]]
- 61% — Homolong 40 [Insulin biphasic [human biosynthetic] and more 1Insulin human]
- 61% — Biosulin 30/70 [Insulin biphasic [human biosynthetic]]
- 61% — Humulin L [Insulin biphasic [human biosynthetic] and more 1Insulin human]
- 60% 17.3-18.4€ Onglyza [Saxagliptin]
- 60% 1.2-2.1€ Gliclazide MR [Gliclazide]
- 60% — Pioglitazone hydrochloride [Pioglitazone]
- 60% — Chlorpropamid [Chlorpropamide]
- 60% — Тресиба [Insulin degludec]
- 60% — Astrozone [Pioglitazone]
- 60% 15.5-17.2€ Trajenta [Linagliptin]
- 60% 2.2-2.3€ Gliclazide MV-VERTEX [Gliclazide]
- 60% 0.7-1.7€ Glidiab MV [Gliclazide]
- 60% 6.7-7.8€ Galvus [Vildagliptin]
- 60% 1.1-1.4€ Glidiab [Gliclazide]
- 60% — Roglit [Rosiglitazone]
- 60% 0.9-1.9€ NovoNorm [Repaglinide]
- 60% 2-2.1€ Gliclada [Gliclazide]
- 60% 1.8€ Gliclazide MR PHARMSTANDART [Gliclazide]
- 60% 1-2.1€ Gliclazide Canon [Gliclazide]
- 60% — Diab-norm [Pioglitazone]
- 60% — Zemiglo [Gemigliptin]
- 60% 0.8-3.9€ Glimepiride [Glimepiride]
- 60% — Pioglit [Pioglitazone]
- 60% — Гликлазид Пролонг-АКОС [Gliclazide]
- 60% — Diabinax [Gliclazide]
- 60% — Amalvia [Pioglitazone]
- 59% — Mixtard Penfill [Insulin biphasic [human biosynthetic] and more 1Insulin human]
- 59% — Gensulin R [Insulin soluble [human biosynthetic] and more 1Insulin human]
- 59% — Gensulin M30 [Insulin biphasic [human biosynthetic] and more 1Insulin human]
- 58% 15.6€ NovoMix [Insulin aspart biphasic]
- 58% — РинФаст Микс 30 [Insulin aspart biphasic]
Learn more about the selection of analogues
- The drug has «РинФаст» 4 full analogs, the cheapest - NovoRapid Penfill (15.5-18.3€); 51 analog by action, the most similar - Rayzodeg (29.4-30.3€).
- Medical online service has selected the best substitutes for РинФаст based on its instructions, components, pharmaceutical groups and practical application.
- The table shows the prices of РинФаст analogues to choose the cheapest pills.
- If you have introduced other drugs for registration, substitutes are selected taking into account the assessment of interactions and safety.
- Sometimes, due to the presence of dangerous interactions, it is necessary to use drugs that are similar in effect, sometimes even from different pharmacological groups.